Evidence map›Paper›PMID 35648595›Full record

ArticleTransboundary and emerging diseases2022

Severe acute respiratory syndrome coronavirus 2 and influenza A virus co-infection alters viral tropism and haematological composition in Syrian hamsters.

Hye Kwon Kim, Jung-Ah Kang, Kwang-Soo Lyoo, Tran Bac Le, Yoon Hwan Yeo, Sook-San Wong, Woonsung Na, Daesub Song, Richard J Webby, Mark Zanin and 2 more

Open access · greenAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Hye Kwon KimDepartment of Microbiology, College of Natural Sciences, Chungbuk National University, Cheongju, Republic of Korea.ORCID https://orcid.org/0000-0003-3458-3403
Jung-Ah KangBionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.
Kwang-Soo LyooKorea Zoonosis Research Institute, Chonbuk National University, Iksan, South Korea.
Tran Bac LeBionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.
Yoon Hwan YeoKorea Zoonosis Research Institute, Chonbuk National University, Iksan, South Korea.
Sook-San WongSchool of Public Health, The University of Hong Kong, Hong Kong.
Woonsung NaCollege of Veterinary Medicine, Chonnam National University, Gwangju, South Korea.
Daesub SongCollege of Veterinary Medicine, Seoul National University, Seoul, South Korea.
Richard J WebbyDivision of Virology, Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID https://orcid.org/0000-0002-4397-7132
Mark ZaninSchool of Public Health, The University of Hong Kong, Hong Kong.
Dae Gwin JeongBionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.ORCID https://orcid.org/0000-0002-0764-1404
Sun-Woo YoonBionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.ORCID https://orcid.org/0000-0003-2061-9743
Korea Research Institute of Bioscience and Biotechnology · KRJeonbuk National University · KRUniversity of Hong Kong · HKChonnam National University · KRChungbuk National University · KRSeoul National University · KRSt. Jude Children's Research Hospital · US

Funding

Bio & Medical Technology Development Program of the National Research Foundation (NRF) and funded by the Korean government (MSIT) 2021M3H9A3020933Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT 2021M3A91208049511National Research Foundation of Korea (NRF) funded by the Korean government 2020R1A2C2009262
6 · The paper itself

Abstract

The ongoing coronavirus disease 2019 pandemic and its overlap with the influenza season lead to concerns over severe disease caused by the influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infections. Using a Syrian hamster co-infection model with SARS-CoV-2 and the pandemic influenza virus A/California/04/2009 (H1N1), we found (a) more severe disease in co-infected animals, compared to those infected with influenza virus alone but not SARS-CoV-2 infection alone; (b) altered haematological changes in only co-infected animals and (c) altered influenza virus tropism in the respiratory tracts of co-infected animals. Overall, our study revealed that co-infection with SARS-CoV-2 and influenza virus is associated with altered disease severity and tissue tropism, as well as haematological changes, compared to infection with either virus alone.

Indexed as

CoinfectionCOVID-19Influenza A Virus, H1N1 SubtypeInfluenza, HumanAnimalsCricetinaeHumansMesocricetusSARS-CoV-2Viral Tropismco-infectionhaematological changeinfluenza A virusSARS-CoV-2viral tropism

Identifiers

PMID35648595
PMCPMC9347909
OpenAlexW4281650046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.